GlassScriptPhysician profile
Ira L Raff
NPI 1609807452
$1,723.80
in general payments reported to CMS, 2019-2025
18 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $82.49 · 2021: $364 · 2022: $296 · 2023: $351 · 2024: $198 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.93 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $386.78 | 2019-2024 | Erleada |
| Astellas Pharma US INC | $208.85 | 2019-2023 | Myrbetriq |
| Coloplast Corp | $170.84 | 2019-2023 | Speedicath |
| Axonics, INC. | $116.63 | 2021 | |
| Abbvie INC. | $115.41 | 2019 | |
| Procept Biorobotics Corporation | $113.91 | 2023 | Aquabeam Robotic System |
| Tolmar, INC. | $99.37 | 2023-2025 | Eligard, Jatenzo |
| Tolmar Pharmaceuticals, INC. | $88.43 | 2022 | |
| Myriad Genetic Laboratories, INC. | $85.31 | 2024 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $59.40 | 2021-2025 | Imfinzi |
| Bayer Healthcare Pharmaceuticals INC. | $56.32 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $52.11 | 2023-2024 | Endosheath Technology |
| Pfizer INC. | $47.04 | 2022-2025 | |
| Immunitybio, INC. | $40.26 | 2025 | |
| Alnylam Pharmaceuticals INC. | $27.49 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $21.89 | 2024 | Urolift |
| Olympus America INC. | $17.35 | 2025 | Itind System |
| Endo Pharmaceuticals INC. | $16.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Raff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.